Affiliation:
1. Institute of Medical Informatics, University of Münster, 48149 Münster, Germany
2. Department of Computer Science, University of Münster, 48149 Münster, Germany
Abstract
The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not systematically assessed. We developed clevRsim—an approach to simulate clonal evolution data, including single-nucleotide variants as well as (overlapping) copy number variants. From this, we generated 88 data sets and performed a systematic evaluation of the tools for the reconstruction of clonal evolution. The results indicate a major negative influence of a high number of clones on both clustering and tree reconstruction. Low coverage as well as an extreme number of time points usually leads to poor clustering results. An underlying branched independent evolution hampers correct tree reconstruction. A further major decline in performance could be observed for large deletions and duplications overlapping single-nucleotide variants. In summary, to explore the full potential of reconstructing clonal evolution, improved algorithms that can properly handle the identified limitations are greatly needed.
Funder
Open Access Publication Fund of the University of Münster
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference42 articles.
1. (2023, January 29). Global Cancer Observatory: Cancer Today, Available online: https://gco.iarc.fr/today.
2. World Cancer Research Fund International (2023, January 29). Cancer Survival Statistics. Available online: https://www.wcrf.org/cancer-trends/cancer-survival-statistics/.
3. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials;Alexander;Cancer,2017
4. Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence;Rockberg;Int. J. Cancer,2016
5. Kundu, S.C., and Reis, R.L. (2020). Materials Today: Biomaterials for 3D Tumor Modeling, Elsevier.